Over a decade spent treating and researching substance use disorders taught one researcher that the overdose epidemic is a ...
Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and ...
The percentage of patients receiving medication for opioid use disorder in federally qualified health centers increased from 2017 to 2023.
For patients with psychiatric conditions from addiction to mood disorders such as depression, disrupted sleep can often ...
Importantly, poor sleep is common throughout a person's experience with opioid use disorder, from actively using to withdrawal from opioids, and even while on treatment. This complication can have ...
LICADD has been addressing substance use for nearly 70 years, but that fight is not stopping, nor is it's intensity lessening ...
The medications “help to bridge that gap between 'I want to get clean' and getting clean," a prisons official said.
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
Adial Pharmaceuticals (ADIL) announced patent number 12,221,654 was issued on February 11, 2025, by the United States Patent and Trademark ...